Kuala Lumpur, Malaysia, 10 October 2024 – TMC Fertility, one of Malaysia’s leading fertility centres, is proud to announce a strategic partnership with Inti Labs, the pioneers behind the non-invasive ORA™ Endometrial Receptivity Test. This collaboration is set to transform fertility treatment in Malaysia, significantly boosting IVF success rates and offering patients a more personalised and effective path to parenthood.
The ORA™ test, developed by Inti Labs, is a cutting-edge advancement in fertility care. This non-invasive genetic test determines the optimal window for embryo transfer, maximising the chances of successful implantation and pregnancy. Unlike traditional methods that require invasive endometrial biopsies, the ORA™ test only requires a simple blood sample, providing patients with a comfortable and highly accurate alternative. By integrating the ORA™ test into its treatment protocols, TMC Fertility continues its commitment to delivering the highest standard of fertility care.
“We are excited to partner with TMC Fertility, a leader in reproductive medicine,” said Eric Pok Yang, Chief Executive Officer of Inti Labs. “Our ORA™ test has the potential to revolutionise fertility outcomes, especially for patients facing complex fertility challenges. We look forward to seeing the transformative impact this collaboration will have on TMC Fertility’s patients.”
Lakshmi Menon, Chief Executive Officer of TMC Fertility, echoed this enthusiasm: “Partnering with Inti Labs to introduce the ORA™ test represents a pivotal milestone in our mission to provide cutting-edge, personalised fertility treatments. This innovative test allows us to tailor our approach for each woman, enhancing their chances for a successful pregnancy. After 30 years of delivering advanced fertility solutions, we are thrilled to offer this new level of care to our patients.”
Dr. Chong Kuoh Ren and Dr Liza Ling Ping Consultant Obstetrician & Gynaecologist and Fertility Specialists at TMC Fertility,added , “Integrating the ORA™ test into our IVF treatments is a major step forward in personalised reproductive care. This collaboration with Inti Labs enables us to deliver the most advanced fertility solutions available, improving the precision and effectiveness of our treatments and increasing our patients’ chances of success.”
This partnership underscores a shared dedication to innovation and excellence in fertility care. Patients at TMC Fertility will now benefit from the enhanced precision and individualised care that the ORA™ test provides, ensuring the best possible outcomes in their fertility journey.
For more information on TMC Fertility and the ORA™ Endometrial Receptivity Test, please visit TMC Fertility and Inti Labs.
